121 related articles for article (PubMed ID: 14982211)
21. Pharmacologic treatment of cancer pain.
Bruera E; Fainsinger RL
N Engl J Med; 1997 Mar; 336(13):962-3; author reply 963. PubMed ID: 9072703
[No Abstract] [Full Text] [Related]
22. Methadone in cancer pain management: individualize dose and titrate to effect.
Foley KM; Houde RW
J Clin Oncol; 1998 Oct; 16(10):3213-5. PubMed ID: 9779693
[No Abstract] [Full Text] [Related]
23. Pitfalls of opioid rotation: substituting another opioid for methadone in patients with cancer pain.
Moryl N; Santiago-Palma J; Kornick C; Derby S; Fischberg D; Payne R; Manfredi PL
Pain; 2002 Apr; 96(3):325-328. PubMed ID: 11973005
[TBL] [Abstract][Full Text] [Related]
24. Bioavailability of morphine, methadone, hydromorphone, and oxymorphone following buccal administration in cats.
Pypendop BH; Ilkiw JE; Shilo-Benjamini Y
J Vet Pharmacol Ther; 2014 Jun; 37(3):295-300. PubMed ID: 24236993
[TBL] [Abstract][Full Text] [Related]
25. A German model for methadone conversion.
Nauck F; Ostgathe C; Dickerson ED
Am J Hosp Palliat Care; 2001; 18(3):200-2. PubMed ID: 11406897
[No Abstract] [Full Text] [Related]
26. Opioid plasma concentrations during a switch from transdermal fentanyl to methadone.
Mercadante S; Villari P; Ferrera P; Casuccio A; Gambaro V
J Palliat Med; 2007 Apr; 10(2):338-44. PubMed ID: 17472504
[TBL] [Abstract][Full Text] [Related]
27. Morphine-methadone opioid rotation in cancer patients: analysis of dose ratio predicting factors.
Benítez-Rosario MA; Salinas-Martín A; Aguirre-Jaime A; Pérez-Méndez L; Feria M
J Pain Symptom Manage; 2009 Jun; 37(6):1061-8. PubMed ID: 19171458
[TBL] [Abstract][Full Text] [Related]
28. Switching from morphine to methadone to improve analgesia and tolerability in cancer patients: a prospective study.
Mercadante S; Casuccio A; Fulfaro F; Groff L; Boffi R; Villari P; Gebbia V; Ripamonti C
J Clin Oncol; 2001 Jun; 19(11):2898-904. PubMed ID: 11387363
[TBL] [Abstract][Full Text] [Related]
29. Conversion from parenteral to oral methadone.
González-Barboteo J; Porta-Sales J; Sánchez D; Tuca A; Gómez-Batiste X
J Pain Palliat Care Pharmacother; 2008; 22(3):200-5. PubMed ID: 19042849
[TBL] [Abstract][Full Text] [Related]
30. Equianalgesia: applying evidence-based practice guidelines.
Bond BS
Clin J Oncol Nurs; 2008 Jun; 12(3):527-9. PubMed ID: 18515253
[No Abstract] [Full Text] [Related]
31. Dose ratios between high dose oral morphine or equivalents and oral methadone.
Chatham MS; Dodds Ashley ES; Svengsouk JS; Juba KM
J Palliat Med; 2013 Aug; 16(8):947-50. PubMed ID: 23662952
[TBL] [Abstract][Full Text] [Related]
32. Methadone for cancer pain: what have we learned from clinical studies?
Soares LG
Am J Hosp Palliat Care; 2005; 22(3):223-7. PubMed ID: 15909785
[TBL] [Abstract][Full Text] [Related]
33. Opioid therapy for chronic painful conditions.
Burgess FW
Med Health R I; 2001 Oct; 84(10):323-6. PubMed ID: 11693049
[No Abstract] [Full Text] [Related]
34. Is oral methadone better than placebo or other oral/transdermal opioids in the management of pain?
Cherny N
Palliat Med; 2011 Jul; 25(5):488-93. PubMed ID: 21708855
[TBL] [Abstract][Full Text] [Related]
35. Treatment of acute pain in opioid tolerant patients.
Bean HK; Gannon R
Conn Med; 2010 Mar; 74(3):143-8. PubMed ID: 20391820
[No Abstract] [Full Text] [Related]
36. Methadone overdose deaths rise with increased prescribing for pain.
Kuehn BM
JAMA; 2012 Aug; 308(8):749-50. PubMed ID: 22910739
[No Abstract] [Full Text] [Related]
37. Methadone as an additional opioid for a cancer patient with severe neuropathic and bone pain not responsive to other opioids and adjuvant analgesics.
Leppert W; Kowalski G
J Palliat Care; 2013; 29(2):119-21. PubMed ID: 23923476
[No Abstract] [Full Text] [Related]
38. Rapid switching between transdermal fentanyl and methadone in cancer patients.
Mercadante S; Ferrera P; Villari P; Casuccio A
J Clin Oncol; 2005 Aug; 23(22):5229-34. PubMed ID: 16051965
[TBL] [Abstract][Full Text] [Related]
39. Morphine to methadone conversion: an interpretation of published data.
Pollock AB; Tegeler ML; Morgan V; Baumrucker SJ
Am J Hosp Palliat Care; 2011 Mar; 28(2):135-40. PubMed ID: 20555039
[TBL] [Abstract][Full Text] [Related]
40. A formal feasibility study of sublingual methadone for breakthrough cancer pain.
Hagen NA; Moulin DE; Brasher PM; Biondo PD; Eliasziw M; Watanabe SM; Stiles CR
Palliat Med; 2010 Oct; 24(7):696-706. PubMed ID: 20671005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
